Market Closed -
Japan Exchange
02:00:00 2024-06-03 am EDT
|
5-day change
|
1st Jan Change
|
1,165
JPY
|
-8.84%
|
|
+20.10%
|
+81.75%
|
Fiscal Period: November |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,172
|
1,822
|
1,479
|
1,306
|
2,425
|
-
|
-
|
Enterprise Value (EV)
1 |
2,900
|
2,260
|
2,975
|
2,812
|
2,425
|
2,425
|
2,425
|
P/E ratio
|
29.2
x
|
1,394
x
|
-5.8
x
|
19.2
x
|
33.5
x
|
18.1
x
|
12.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.78
x
|
0.44
x
|
0.3
x
|
0.22
x
|
0.38
x
|
0.36
x
|
0.33
x
|
EV / Revenue
|
0.78
x
|
0.44
x
|
0.3
x
|
0.22
x
|
0.38
x
|
0.36
x
|
0.33
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-19,343,391
x
|
-
|
-2,843,749
x
|
-11,456,135
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
2.34
x
|
1.37
x
|
1.36
x
|
1.13
x
|
1.99
x
|
1.79
x
|
1.56
x
|
Nbr of stocks (in thousands)
|
2,090
|
2,075
|
2,092
|
2,100
|
2,081
|
-
|
-
|
Reference price
2 |
1,518
|
878.0
|
707.0
|
622.0
|
1,165
|
1,165
|
1,165
|
Announcement Date
|
1/14/21
|
1/14/22
|
1/17/23
|
1/18/24
|
-
|
-
|
-
|
Fiscal Period: November |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,086
|
4,114
|
4,904
|
5,915
|
6,342
|
6,771
|
7,286
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
106
|
-234
|
-215
|
20
|
126
|
221
|
317
|
Operating Margin
|
2.59%
|
-5.69%
|
-4.38%
|
0.34%
|
1.99%
|
3.26%
|
4.35%
|
Earnings before Tax (EBT)
|
187
|
64
|
-241
|
75
|
-
|
-
|
-
|
Net income
1 |
102
|
1
|
-253
|
67
|
73
|
135
|
199
|
Net margin
|
2.5%
|
0.02%
|
-5.16%
|
1.13%
|
1.15%
|
1.99%
|
2.73%
|
EPS
2 |
51.98
|
0.6300
|
-121.8
|
32.35
|
34.80
|
64.30
|
94.80
|
Free Cash Flow
|
-164
|
-
|
-520
|
-114
|
-
|
-
|
-
|
FCF margin
|
-4.01%
|
-
|
-10.6%
|
-1.93%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/14/21
|
1/14/22
|
1/17/23
|
1/18/24
|
-
|
-
|
-
|
Fiscal Period: November |
2020 S1
|
2021 S1
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
---|
Net sales
1 |
1,992
|
1,988
|
1,095
|
2,318
|
1,265
|
1,356
|
2,843
|
1,539
|
1,501
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
17
|
-95
|
-92
|
-111
|
-53
|
-84
|
-103
|
33
|
10
|
Operating Margin
|
0.85%
|
-4.78%
|
-8.4%
|
-4.79%
|
-4.19%
|
-6.19%
|
-3.62%
|
2.14%
|
0.67%
|
Earnings before Tax (EBT)
1 |
56
|
-11
|
-102
|
-113
|
-53
|
-76
|
-85
|
43
|
14
|
Net income
1 |
37
|
-21
|
-75
|
-84
|
-30
|
-54
|
-64
|
23
|
5
|
Net margin
|
1.86%
|
-1.06%
|
-6.85%
|
-3.62%
|
-2.37%
|
-3.98%
|
-2.25%
|
1.49%
|
0.33%
|
EPS
2 |
20.01
|
-10.20
|
-36.19
|
-40.58
|
-14.56
|
-26.03
|
-30.97
|
11.37
|
2.400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/14/20
|
7/14/21
|
4/14/22
|
7/14/22
|
10/14/22
|
4/14/23
|
7/14/23
|
10/13/23
|
4/12/24
|
Fiscal Period: November |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
438
|
1,496
|
1,506
|
-
|
-
|
-
|
Net Cash position
|
272
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-164
|
-
|
-520
|
-114
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.6%
|
0.1%
|
-21%
|
6.1%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
6.7%
|
0.91%
|
-4.03%
|
1.34%
|
-
|
-
|
-
|
Assets
1 |
1,522
|
109.8
|
6,283
|
5,002
|
-
|
-
|
-
|
Book Value Per Share
2 |
648.0
|
642.0
|
518.0
|
551.0
|
586.0
|
651.0
|
746.0
|
Cash Flow per Share
|
82.50
|
33.10
|
-71.50
|
89.60
|
-
|
-
|
-
|
Capex
1 |
172
|
688
|
418
|
211
|
160
|
160
|
160
|
Capex / Sales
|
4.21%
|
16.72%
|
8.52%
|
3.57%
|
2.52%
|
2.36%
|
2.2%
|
Announcement Date
|
1/14/21
|
1/14/22
|
1/17/23
|
1/18/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +81.75% | 16.92M | | +22.17% | 88.99B | | -24.08% | 74.82B | | +1.06% | 26.63B | | +3.92% | 17.88B | | -13.78% | 16.43B | | +2.38% | 15.77B | | +76.71% | 13.21B | | +70.66% | 13.08B | | +39.35% | 12.9B |
Other Healthcare Facilities & Services
|